Atlas FDA

Orsiro Sirolimus Eluting Coronary Stent System

FDA premarket approval P170030/S008 · decided 2020-08-20

Approval details

PMA number
P170030
Supplement
S008
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Orsiro Sirolimus Eluting Coronary Stent System
Generic name
Coronary drug-eluting stent
Applicant
Biotronik AG
Date received
2020-07-22
Decision date
2020-08-20
Days to decision
29 days
Decision code
OK30
Product code
NIQ
Advisory committee
Cardiovascular
Expedited review
No
Location
Bülach
Statement
Addition of identical ultrasonic cleaning machines and updates to the cleaning parameters.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
PHERON PERIPHERAL PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) CATHETER (K052757)Biotronik AG2005-10-28